has been revised to 10.51 / share. This is an decrease of ... There are 45 funds or institutions reporting positions in Biora Therapeutics. This is an increase of 4 owner(s) or 9.76% in the ...

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for ...